HIV inhibiting 2-(4-cyanophenyl)-6-hydroxylaminopyrimidines

Details for Australian Patent Application No. 2006222057 (hide)

Owner Tibotec Pharmaceuticals Ltd.

Inventors De Kock, Herman Augustinus; Wigerinck, Piet Tom Bert Paul

Agent Shelston IP

Pub. Number AU-B-2006222057

PCT Pub. Number WO2006/094930

Priority 05101707.7 04.03.05 EP

Filing date 2 March 2006

Wipo publication date 14 September 2006

Acceptance publication date 4 October 2012

International Classifications

C07D 239/48 Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

A61K 31/505 - Pyrimidines

A61P 31/18 Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

C07D 405/12 Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

Event Publications

19 July 2007 Amendment Made

  The nature of the amendment is: Amend the co-inventor name from Wigerinck, Piet Piet Tom Bert Paul to Wigerinck, Piet Tom Bert Paul 2007

19 July 2007 PCT application entered the National Phase

  PCT publication WO2006/094930 Priority application(s): WO2006/094930

4 October 2012 Application Accepted

  Published as AU-B-2006222057

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006222060-Roflumilast for the treatment of diabetes mellitus

2006222048-Process for the preparation of 1-aminopiperidine derivatives